SARS-CoV-2 research using human pluripotent stem cells and organoids

S Deguchi, Á Serrano-Aroca… - Stem Cells …, 2021 - academic.oup.com
Experimental cell models are indispensable for clarifying the pathophysiology of coronavirus
disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome …

Usability of polydimethylsiloxane-based microfluidic devices in pharmaceutical research using human hepatocytes

S Deguchi, M Tsuda, K Kosugi… - ACS Biomaterials …, 2021 - ACS Publications
A liver-on-a-chip (liver-chip) is a microfluidic device carrying liver cells such as human
hepatocytes. It is used to reproduce a part of liver function. Many microfluidic devices are …

[HTML][HTML] Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

…, Y Oda, S Lytras, N Nao, Y Itakura, S Deguchi… - Nature …, 2023 - nature.com
In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is
spreading rapidly around the world. Our phylogenetic analyses suggested that XBB …

Generation of human induced pluripotent stem cell-derived hepatocyte-like cells for cellular medicine

S Deguchi, K Takayama, H Mizuguchi - … and Pharmaceutical Bulletin, 2020 - jstage.jst.go.jp
Liver transplantation and hepatocyte transplantation are effective treatments for severe liver
injuries, but the donor shortage is a serious problem. Therefore, hepatocyte-like cells …

[HTML][HTML] Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant

…, Y Itakura, J Zahradnik, KT Kimura, S Deguchi… - Nature …, 2023 - nature.com
In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These
variants convergently acquired amino acid substitutions at critical residues in the spike protein, …

SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression

…, K Shirakura, R Funatsu, K Kosugi, S Deguchi… - Science …, 2022 - science.org
In the initial process of coronavirus disease 2019 (COVID-19), severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infects respiratory epithelial cells and then transfers to …

[PDF][PDF] Virological characteristics of the SARS-CoV-2 BA. 2.86 variant

T Tamura, K Mizuma, H Nasser, S Deguchi… - Cell Host & Microbe, 2024 - cell.com
In late 2023, several SARS-CoV-2 XBB descendants, notably EG.5.1, were predominant
worldwide. However, a distinct SARS-CoV-2 lineage, the BA.2.86 variant, also emerged. BA.…

Organ-on-a-chip models for elucidating the cellular biology of infectious diseases

F Yokoi, S Deguchi, K Takayama - … et Biophysica Acta (BBA)-Molecular Cell …, 2023 - Elsevier
Infectious diseases are caused by the invasion of pathogens into a host. To explore the
mechanisms of pathogen infections and cellular responses, human models that can accurately …

[HTML][HTML] State-of-the-art liver disease research using liver-on-a-chip

S Deguchi, K Takayama - Inflammation and Regeneration, 2022 - Springer
To understand disease pathophysiologies, models that recapitulate human functions are
necessary. In vitro models that consist of human cells are preferred to ones using animal cells, …

Modeling of hepatic drug metabolism and responses in CYP2C19 poor metabolizer using genetically manipulated human iPS cells

S Deguchi, T Yamashita, K Igai, K Harada… - Drug Metabolism and …, 2019 - ASPET
Cytochrome P450 family 2 subfamily C member 19 (CYP2C19), in liver, plays important
roles in terms of drug metabolism. It is known that CYP2C19 poor metabolizers (PMs) lack …